Lipoprotein(a)-Lowering by 50 mg/dL (105 nmol/L) May Be Needed to Reduce Cardiovascular Disease 20% in Secondary Prevention
出版年份 2019 全文链接
标题
Lipoprotein(a)-Lowering by 50 mg/dL (105 nmol/L) May Be Needed to Reduce Cardiovascular Disease 20% in Secondary Prevention
作者
关键词
-
出版物
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
Volume 40, Issue 1, Pages 255-266
出版商
Ovid Technologies (Wolters Kluwer Health)
发表日期
2019-10-03
DOI
10.1161/atvbaha.119.312951
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Lipoprotein(a), PCSK9 Inhibition and Cardiovascular Risk: Insights from the FOURIER Trial
- (2019) Michelle L. O'Donoghue et al. CIRCULATION
- 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol
- (2019) Scott M. Grundy et al. CIRCULATION
- Estimation of the Required Lipoprotein(a)-Lowering Therapeutic Effect Size for Reduction in Coronary Heart Disease Outcomes
- (2019) Claudia Lamina et al. JAMA Cardiology
- Quantifying Atherogenic Lipoproteins: Current and Future Challenges in the Era of Personalized Medicine and Very Low Concentrations of LDL Cholesterol. A Consensus Statement from EAS and EFLM
- (2018) Michel R. Langlois et al. CLINICAL CHEMISTRY
- Cardiovascular disease risk associated with elevated lipoprotein(a) attenuates at low low-density lipoprotein cholesterol levels in a primary prevention setting
- (2018) Rutger Verbeek et al. EUROPEAN HEART JOURNAL
- Advances in lipid-lowering therapy through gene-silencing technologies
- (2018) Børge G. Nordestgaard et al. Nature Reviews Cardiology
- Association of Lipoprotein(a) With Risk of Recurrent Ischemic Events Following Acute Coronary Syndrome
- (2018) Gregory G. Schwartz et al. JAMA Cardiology
- Association of LPA Variants With Risk of Coronary Disease and the Implications for Lipoprotein(a)-Lowering Therapies
- (2018) Stephen Burgess et al. JAMA Cardiology
- Lipoprotein(a) and secondary prevention of atherothrombotic events: A critical appraisal
- (2018) Michael B. Boffa et al. Journal of Clinical Lipidology
- Baseline and on-statin treatment lipoprotein(a) levels for prediction of cardiovascular events: individual patient-data meta-analysis of statin outcome trials
- (2018) Peter Willeit et al. LANCET
- Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
- (2017) Brian A. Ference et al. EUROPEAN HEART JOURNAL
- Collider scope: when selection bias can substantially influence observed associations
- (2017) Marcus R Munafò et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- A Test in Context: Lipoprotein(a)
- (2017) Sotirios Tsimikas JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Relations between lipoprotein(a) concentrations, LPA genetic variants, and the risk of mortality in patients with established coronary heart disease: a molecular and genetic association study
- (2017) Stephen Zewinger et al. Lancet Diabetes & Endocrinology
- Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points—a joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine
- (2016) Børge G. Nordestgaard et al. EUROPEAN HEART JOURNAL
- 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
- (2016) Alberico L. Catapano et al. EUROPEAN HEART JOURNAL
- Structure, function, and genetics of lipoprotein (a)
- (2016) Konrad Schmidt et al. JOURNAL OF LIPID RESEARCH
- Lipoprotein (a) as a cause of cardiovascular disease: insights from epidemiology, genetics, and biology
- (2016) Børge G. Nordestgaard et al. JOURNAL OF LIPID RESEARCH
- Phenotypic Characterization of Genetically Lowered Human Lipoprotein(a) Levels
- (2016) Connor A. Emdin et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Antisense oligonucleotides targeting apolipoprotein(a) in people with raised lipoprotein(a): two randomised, double-blind, placebo-controlled, dose-ranging trials
- (2016) Nicholas J Viney et al. LANCET
- High lipoprotein(a) as a possible cause of clinical familial hypercholesterolaemia: a prospective cohort study
- (2016) Anne Langsted et al. Lancet Diabetes & Endocrinology
- Elevated Lipoprotein(a) Levels, LPA Risk Genotypes, and Increased Risk of Heart Failure in the General Population
- (2016) Pia R. Kamstrup et al. JACC-Heart Failure
- ‘LDL-C’ = LDL-C + Lp(a)-C
- (2015) Calvin Yeang et al. CURRENT OPINION IN LIPIDOLOGY
- Elevated Lipoprotein(a) Does Not Cause Low-Grade Inflammation Despite Causal Association With Aortic Valve Stenosis and Myocardial Infarction: A Study of 100 578 Individuals from the General Population
- (2015) Anne Langsted et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Lipoprotein(a) for Risk Assessment in Patients With Established Coronary Artery Disease
- (2013) Michelle L. O'Donoghue et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Elevated Lipoprotein(a) and Risk of Aortic Valve Stenosis in the General Population
- (2013) Pia R. Kamstrup et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Genetic Associations with Valvular Calcification and Aortic Stenosis
- (2013) George Thanassoulis et al. NEW ENGLAND JOURNAL OF MEDICINE
- Index Event Bias as an Explanation for the Paradoxes of Recurrence Risk Research
- (2011) Issa J. Dahabreh JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Clinical utility of inflammatory markers and advanced lipoprotein testing: Advice from an expert panel of lipid specialists
- (2011) Michael H. Davidson et al. Journal of Clinical Lipidology
- Lipoprotein(a) as a cardiovascular risk factor: current status
- (2010) Børge G. Nordestgaard et al. EUROPEAN HEART JOURNAL
- Genetically Elevated Lipoprotein(a) and Increased Risk of Myocardial Infarction
- (2009) Pia R. Kamstrup JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Lipoprotein(a) Concentration and the Risk of Coronary Heart Disease, Stroke, and Nonvascular Mortality
- (2009) JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Genetic Variants Associated with Lp(a) Lipoprotein Level and Coronary Disease
- (2009) Robert Clarke et al. NEW ENGLAND JOURNAL OF MEDICINE
- Extreme Lipoprotein(a) Levels and Risk of Myocardial Infarction in the General Population
- (2007) Pia R. Kamstrup et al. CIRCULATION
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now